- US-listed companies
- GILEAD SCIENCES, INC.
- Financials
- Accounts receivable, net
GILEAD SCIENCES, INC.GILD
Market cap
$155.4B
P/E ratio
| Period End | Accounts receivable, net (Million USD) | YoY (%) |
|---|---|---|
| Dec 31, 2024 | 4,420 | -5.15% |
| Dec 31, 2023 | 4,660 | -2.45% |
| Dec 31, 2022 | 4,777 | +6.32% |
| Dec 31, 2021 | 4,493 | -8.16% |
| Dec 31, 2020 | 4,892 | +36.57% |
| Dec 31, 2019 | 3,582 | +7.66% |
| Dec 31, 2018 | 3,327 | -13.61% |
| Dec 31, 2017 | 3,851 | -14.69% |
| Dec 31, 2016 | 4,514 | -22.89% |
| Dec 31, 2015 | 5,854 | +26.30% |
| Dec 31, 2014 | 4,635 | +120.68% |
| Dec 31, 2013 | 2,100 | +19.92% |
| Dec 31, 2012 | 1,751 | -10.24% |
| Dec 31, 2011 | 1,951 | +20.30% |
| Dec 31, 2010 | 1,622 |